The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective study evaluating the effect of impaired tamoxifen metabolisation on efficacy in breast cancer patients receiving tamoxifen in the neo-adjuvant or metastatic setting.
 
Anneleen Lintermans
No Relationships to Disclose
 
Kathleen Van Asten
No Relationships to Disclose
 
Lynn Jongen
No Relationships to Disclose
 
Chantal Blomme
No Relationships to Disclose
 
Diether Lambrechts
No Relationships to Disclose
 
Ben Van Calster
No Relationships to Disclose
 
An Poppe
No Relationships to Disclose
 
Hans Wildiers
No Relationships to Disclose
 
Anne-Sophie Dieudonné
No Relationships to Disclose
 
Jan Decloedt
No Relationships to Disclose
 
Patrick Berteloot
No Relationships to Disclose
 
Didier Verhoeven
No Relationships to Disclose
 
Markus Joerger
No Relationships to Disclose
 
Peter Vuylsteke
No Relationships to Disclose
 
Wim Wynendaele
No Relationships to Disclose
 
Ignace Vergote
Consulting or Advisory Role - AstraZeneca (Inst)
 
Henk-jan Guchelaar
No Relationships to Disclose
 
Vincent O. Dezentje
No Relationships to Disclose
 
Robert Paridaens
No Relationships to Disclose
 
Patrick Neven
No Relationships to Disclose